文献速递乳腺US乳腺X线

真空辅助活检诊断的不确定恶性潜能(B3)乳腺病变的恶性阳性预测值:是否仍推荐手术切除?

Positive predictive value for malignancy of uncertain malignant potential (B3) breast lesions diagnosed on vacuum-assisted biopsy (VAB): is surgical excision still recommended?
PubMed 文献 · Eur Radiol · 2020-08-20

本研究评估了2006年1月至2017年12月在本中心进行的1250次真空辅助乳腺活检中诊断的150例B3病变,其中68例接受手术切除,总体恶性阳性预测值为28%,非典型导管增生最高为41%,经典型小叶瘤变29%,平坦上皮非典型性11%;随访队列仅2例癌,均与真空辅助活检诊断的非典型导管增生相关。作者建议非典型导管增生行开放手术,其他B3病变若满足影像病理相关性评估、所有微钙化被真空辅助活检切除且无高风险细胞学特征,可仅用真空辅助活检切除作为可接受的替代。

要点

  • 非典型导管增生升级率最高(41%),作者推荐手术切除。
  • 平坦上皮非典型性升级率11%,完全切除微钙化后作者认为可建议监测。
  • 孤立经典型小叶瘤变在影像病理相关时可仅随访。

核心结论

  • B3病变总体恶性阳性预测值为28%,非典型导管增生最高(41%),经典型小叶瘤变29%,平坦上皮非典型性11%。
  • 非典型导管增生推荐开放手术;其他B3病变在满足影像病理相关性评估、所有微钙化被真空辅助活检切除且无高风险细胞学特征时,仅用真空辅助活检切除可能是可接受的替代。
  • 随访队列仅检测到2例癌,均与真空辅助活检诊断的非典型导管增生相关。

研究设计与样本

  • 单中心研究,2006年1月至2017年12月共进行1250次真空辅助乳腺活检,诊断150例B3病变,其中68例接受手术切除并与切除组织学相关性分析。
  • 另有一个B3病变随访队列,比较其与手术切除队列的结果。

诊断标准与关键数值

  • B3病变总体恶性阳性预测值为28%。
  • 非典型导管增生升级率为41%。
  • 经典型小叶瘤变升级率为29%。
  • 平坦上皮非典型性升级率为11%。

临床应用与阅片要点

  • 作者建议非典型导管增生行开放手术。
  • 作者认为其他B3病变在评估影像病理相关性、所有微钙化被真空辅助活检切除且病变无高风险细胞学特征时,仅用真空辅助活检切除可能是可接受的替代。
  • 作者强烈推荐非典型导管增生行手术治疗;对于纯平坦上皮非典型性,尤其真空辅助活检完全切除微钙化后,升级率可能足够低,可建议监测作为管理策略。
  • 使用11G或8G针真空辅助活检可能实现病变的完全诊断性切除,在放射状瘢痕情况下可作为可接受的替代,仅对选定的高风险患者考虑开放手术。
  • 小叶瘤变管理更具争议:经典型小叶瘤变活检诊断时若同时检测到另一个B3病变,可推荐手术切除;若为孤立小叶瘤变且影像病理相关性充分,单独随访可能是可接受的选择。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: Breast lesions classified as of "uncertain malignant potential" represent a heterogeneous group of abnormalities with an increased risk of associated malignancy. Clinical management of B3 lesions diagnosed on vacuum-assisted breast biopsy (VABB) is still challenging: surgical excision is no longer the only available treatment and VABB may be sufficient for therapeutic excision. The aim of the present study is to evaluate the positive predictive value (PPV) for malignancy in B3 lesions that underwent surgical excision, identifying possible upgrading predictive factors and characterizing the malignant lesions eventually diagnosed. These results are compared with a subset of patients with B3 lesions who underwent follow-up.

METHODS: A total of 1250 VABBs were performed between January 2006 and December 2017 at our center. In total, 150 B3 cases were diagnosed and 68 of them underwent surgical excision. VABB findings were correlated with excision histology. A PPV for malignancy for each B3 subtype was derived.

RESULTS: The overall PPV rate was 28%, with the highest upgrade rate for atypical ductal hyperplasia (41%), followed by classical lobular neoplasia (29%) and flat epithelial atypia (11%). Only two cases of carcinoma were detected in the follow-up cohort, both associated with atypical ductal hyperplasia at VABB.

CONCLUSION: Open surgery is recommended in case of atypical ductal hyperplasia while, for other B3 lesions, excision with VABB only may be an acceptable alternative if radio-pathological correlation is assessed, if all microcalcifications have been removed by VABB, and if the lesion lacks high-risk cytological features.

KEY POINTS: • Surgical treatment is strongly recommended in case of ADH, while the upgrade rate in case of pure FEA, especially following complete microcalcification removal by VABB, may be sufficiently low to advice surveillance as a management strategy. • The use of 11-G- or 8-G-needle VABB, resulting in possible complete diagnostic excision of the lesion, can be an acceptable alternative in case of RS, considering open surgery only for selected high-risk patients. • LN management is more controversial: surgical excision may be recommended following classical LN diagnosis on breast biopsy if an additional B3 lesion is concurrently detected while in the presence of isolated LN with adequate radiological-pathological correlation follow-up alone could be an acceptable option.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Lucioni M, Rossi C, Lomoro P, et al. Positive predictive value for malignancy of uncertain malignant potential (B3) breast lesions diagnosed on vacuum-assisted biopsy (VAB): is surgical excision still recommended? Eur Radiol. 2020. PMID: 32816199. doi:10.1007/s00330-020-07161-5

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。